01 Nov
  • By leilanifera
  • Cause in

Capricor Therapeutics

Approach: Cardiac stem cell derived therapy
Funding Impact: Initiation of Phase 1/2 study (HOPE Clinical Trial)
Successful Exit: Stock Return

READ MORE